Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > I’ll help you out on the when.
View:
Post by alleyesonme on Oct 04, 2023 10:57pm

I’ll help you out on the when.

JUNE 2025...this is when the FDA's mandatory 30 month stay from selling such generics expires...this 30 month period is automatically imposed on defendants in an infringement lawsuit(FACT)..one of these defendants is our GLOBAL Pharmaceutical PARTNER.(FACT) Between now and then the news of WHO will drop...wait for it......APOTEX....shhh it's a secret..lol jk just my geuss on WHO I don't actually know...P.S...I was the guy yelling EPIDIOLEX generic as soon as the news about filing DMF for cannabidol..NO ONE but ED A.K.A Subaru1a concurred...thanks bud..we were bang on.
Comment by mdjbrown on Oct 05, 2023 10:23am
alleysome, dont be surprised if one of these generic Epidiolex suitors beats the 30 month stay through an FDA orange book patent challenge.  Also dont be surprised if a similiar drug appears in Brazil through Verdemed   Jazz (GW) faced the same music with Avadel's Lumryz drug, lost that infringement lawsuit, and decided its best course of action was to sue the FDA.    ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities